Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR

Shenlan Mao, Raghothama Chaerkady, Wen Yu, Gina D’Angelo, Andrew Garcia, Hong Chen, Allison M. Barrett, Sandrina Phipps, Ryan Fleming, Sonja Hess, Jens-Oliver Koopmann, Nazzareno Dimasi, Susan Wilson, Kathryn Pugh, Kimberly Cook, Luke A. Masterson, Changshou Gao, Herren Wu, Ronald Herbst, Philip W. Howard, David A. Tice, Mark Cobbold, Jay Harper

Open source

DOI: 10.1158/1535-7163.mct-20-0351
Published: 2021-03-01
Container: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-20-0351,
  title = {Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR},
  author = {Shenlan Mao and Raghothama Chaerkady and Wen Yu and Gina D’Angelo and Andrew Garcia and Hong Chen and Allison M. Barrett and Sandrina Phipps and Ryan Fleming and Sonja Hess and Jens-Oliver Koopmann and Nazzareno Dimasi and Susan Wilson and Kathryn Pugh and Kimberly Cook and Luke A. Masterson and Changshou Gao and Herren Wu and Ronald Herbst and Philip W. Howard and David A. Tice and Mark Cobbold and Jay Harper},
  year = {2021},
  journal = {Molecular Cancer Therapeutics},
  doi = {10.1158/1535-7163.mct-20-0351},
  url = {https://doi.org/10.1158/1535-7163.mct-20-0351}
}

RIS

TY  - JOUR
TI  - Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
AU  - Shenlan Mao
AU  - Raghothama Chaerkady
AU  - Wen Yu
AU  - Gina D’Angelo
AU  - Andrew Garcia
AU  - Hong Chen
AU  - Allison M. Barrett
AU  - Sandrina Phipps
AU  - Ryan Fleming
AU  - Sonja Hess
AU  - Jens-Oliver Koopmann
AU  - Nazzareno Dimasi
AU  - Susan Wilson
AU  - Kathryn Pugh
AU  - Kimberly Cook
AU  - Luke A. Masterson
AU  - Changshou Gao
AU  - Herren Wu
AU  - Ronald Herbst
AU  - Philip W. Howard
AU  - David A. Tice
AU  - Mark Cobbold
AU  - Jay Harper
PY  - 2021
JO  - Molecular Cancer Therapeutics
DO  - 10.1158/1535-7163.mct-20-0351
UR  - https://doi.org/10.1158/1535-7163.mct-20-0351
ER  -

APA

Mao, S., Chaerkady, R., Yu, W., D’Angelo, G., Garcia, A., Chen, H., Barrett, A. M., Phipps, S., Fleming, R., Hess, S., Koopmann, J., Dimasi, N., Wilson, S., Pugh, K., Cook, K., Masterson, L. A., Gao, C., Wu, H., Herbst, R., Howard, P. W., Tice, D. A., Cobbold, M., & Harper, J. (2021). Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-20-0351

Source records

crossref · retrieved 2026-09-27T01:36:59.555Z